Loading the SOTA2 catalog…
FDA-cleared Class II Software as a Medical Device (SaMD) that provides algorithm-based insulin dosing recommendations for intravenous (IV) and subcutaneous (SubQ) delivery.
FDA-cleared Class II Software as a Medical Device (SaMD) that provides algorithm-based insulin dosing recommendations for intravenous (IV) and subcutaneous (SubQ) delivery.
Platforms, integrations, and language support vary by plan and region. Confirm final requirements with the vendor.
Loading community reviews…
Compliance claims are normalized from current vendor documentation and independently reviewed by SOTA2.